Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTA 744 in breast cancer with brain metastases
NCT00538343Phase 2Terminated
- Sponsor
- Biogen
- Start
- Oct 2007
- Primary completion
- Dec 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of berubicin in breast cancer, sponsored by Biogen. Started Oct 2007; status: terminated.
02
Drugs
berubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00538343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538343.